N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide

We are N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide CAS:90357-51-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide
CAS.NO:90357-51-0
Synonyms:N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide
N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyl-Oxiranecarboxamide
N-(4-cyano-3-trifluoromethylphenyl)-2-methyl-oxiranyl-carboxamide
rac-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide
1,2-EPOXY-2-METHYL-N-[4-CYANO-3-(TRIFLUOROMETHYL)]
N-(4-cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 436.4±45.0 °C at 760 mmHg
Molecular Formula C12H9F3N2O2
Molecular Weight 270.207
Flash Point 217.7±28.7 °C
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.526
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bicalutamide(CAS:90357-06-5).

N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide


Related News: According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).447464-03-1 At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival.1-bromo-4-yodobutano CAS:89044-65-5 At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival.(2,4-Dichloro-5-isopropoxyphenyl)hydrazine It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.

Related Products
Product Name
N-(4-(naphthalen-1-yl)phenyl)-[1,1′-biphenyl]-4-amine View Details
Diethyl(3-pyridyl)borane View Details
POLYTRIFLUOROPROPYLMETHYLSILOXANE, SILANOL TERMINATED View Details
N-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine manufacturer 3-Bromo-2-fluorophenylmethanol manufacturer 2,2,2-Trimethylthioacetamide manufacturer 2-[1,1′-Biphenyl]-4-yl-4-chloro-6-phenyl-1,3,5-triazine manufacturer 5-Bromo-m-xylene manufacturer